SLC2A1 and renal cell carcinoma: For example, Zheng et al. found that the TCM Bu-Shen-Jian-Pi-Fang could inhibit tumor proliferation by enhancing GLUT-1 related glycolysis and may alter the immune-rejection microenvironment in renal cell carcinoma patients (37).